Price (delayed)
$73
Market cap
$226.3B
P/E Ratio
29.08
Dividend/share
$1.55
EPS
$2.51
Enterprise value
$252.72B
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
Special dividends are included in TTM DPS and yield
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.